Research LibraryNeurotransmitters
Neurotransmitters9 min readFeb 26, 2026

MAOA: The “Warrior Gene” Explained (Without the Hype)

Monoamine oxidase A breaks down serotonin, dopamine, and norepinephrine after they've done their job. The low-activity variant became famous as the “warrior gene.” The science tells a different story — one about environmental sensitivity, not predestination.

Key Variant

Gene
MAOA
Variants
VNTR (2R/3R = low; 3.5R/4R = high)
rs ID (proxy)
rs6323 (partial capture)
Chromosome
X-linked (Xp11.3)

Detection note: MAOA's primary functional variant is a VNTR (variable number tandem repeat) not captured by standard SNP arrays. 23andMe and AncestryDNA provide partial information via proxy SNPs (rs6323, rs1137070). Full characterization requires whole-genome sequencing.

What MAOA Actually Does

Monoamine oxidase A is an enzyme that lives in the outer mitochondrial membrane of neurons and other cells. Its job is oxidative deamination — breaking down monoamine neurotransmitters into inactive metabolites so they can be cleared from the synapse and eventually excreted.

The substrates it degrades include:

  • Serotonin (5-HT) → 5-hydroxyindoleacetic acid (5-HIAA)
  • Dopamine → homovanillic acid (HVA) and DOPAC
  • Norepinephrine → normetanephrine, then vanillylmandelic acid
  • Epinephrine (adrenaline) → metanephrine
  • Tyramine → key in dietary interactions (see MAO inhibitor drug interactions)

MAOA is the primary enzyme for serotonin and norepinephrine metabolism. COMT handles dopamine more in the prefrontal cortex. MAOA handles it more broadly, especially in the limbic system and brainstem.

COMT vs MAOA: These two enzymes work in sequence. COMT methylates catecholamines first (dopamine, NE, E). MAOA then oxidizes the methylated products (and also acts directly on serotonin, which COMT doesn't touch). If you have slow COMT AND low-activity MAOA, the compounding effect is meaningful — your monoamine clearance is slow on both pathways.

The VNTR Polymorphism: What Low vs. High Activity Means

The primary functional variant in MAOA is a variable number tandem repeat (VNTR) in the promoter region — a sequence of 30 base pairs repeated 2, 3, 3.5, 4, or 5 times. The repeat count determines transcription efficiency:

Repeat CountActivityCommon NamePopulation Freq (European)
2RLowMAOA-L~5-10%
3RLowMAOA-L~25-30%
3.5RHighMAOA-H~5%
4RHighMAOA-H~55-60%
5RHighMAOA-H~5%

MAOA-L (low activity) means your MAOA enzyme is produced in lower quantities. Result: monoamines accumulate higher and clear more slowly in the synapse. You have more serotonin, dopamine, and norepinephrine available at baseline — but also less buffer capacity when these systems get stressed or flooded.

MAOA-H (high activity) means your MAOA clears monoamines rapidly. Lower baseline neurotransmitter levels. Better buffering capacity. Less accumulation under stress. But potentially more vulnerability to depletion states (low serotonin or dopamine baseline).

X-linkage matters: MAOA is on the X chromosome. Men (XY) have one copy — they're either MAOA-L or MAOA-H with no heterozygous state. Women (XX) can be heterozygous (one L, one H allele) and express intermediate activity. This is why MAOA research has historically focused on males.

The “Warrior Gene” Myth and What the Science Actually Shows

In 2002, Avshalom Caspi and colleagues published a landmark study in Science that tracked 442 New Zealand men from birth to age 26. The finding: childhood maltreatment predicted antisocial behavior — but only strongly in men with MAOA-L. In men with MAOA-H, maltreatment had far weaker effects on later behavior.

The media translated this as “MAOA-L = the warrior gene.” That framing is wrong in two important ways:

What the study actually showed:

MAOA-L by itself did NOT predict antisocial behavior. Only the combination of MAOA-L plus childhood maltreatment did. Men with MAOA-L who were NOT maltreated had no elevated risk. The gene moderated the impact of the environment — it didn't determine the outcome.

The differential susceptibility reframe:

Jay Belsky's differential susceptibility framework (2009) reframes this entirely: MAOA-L carriers are more plastic — more responsive to environment in both directions. They're hit harder by adversity AND benefit more from positive environments. The “warrior gene” is actually a sensitivity gene. MAOA-L children raised in nurturing environments often show above-average prosocial behavior and emotional intelligence.

This distinction matters enormously. If you carry MAOA-L, you're not predisposed to anything harmful. You're someone whose nervous system responds more strongly to environmental inputs. That's a feature to optimize, not a sentence to dread.

Your Genotype Profile

MAOA-L (Low Activity: 2R or 3R)

~30-40% of males; higher in some non-European populations

What this means for you:

  • ·Higher baseline serotonin and norepinephrine availability
  • ·Slower clearance of monoamines after release — longer emotional refractory periods
  • ·Higher emotional reactivity, especially to perceived threats or social rejection
  • ·Greater sensitivity to environmental inputs — both positive and negative
  • ·Potential for heightened empathy and emotional attunement
  • ·Risk of serotonin accumulation with high-dose 5-HTP or tryptophan supplements

Your protocol priority:

  • Support methylation (MTHFR, COMT cofactors) — monoamine breakdown is methylation-dependent
  • Stress resilience compounds over monoamine boosters
  • Avoid high-dose serotonin precursors (5-HTP, St. John's Wort)
  • Prioritize sleep — monoamine rebalancing happens predominantly during NREM sleep
  • Regular aerobic exercise — normalizes MAO activity and receptor sensitivity

MAOA-H (High Activity: 3.5R, 4R, or 5R)

~60-70% of males in European populations

What this means for you:

  • ·Rapid monoamine clearance — shorter emotional refractory periods
  • ·Better emotional regulation under stress
  • ·Lower baseline serotonin tone — potential vulnerability to low-mood states
  • ·May benefit more from serotonin precursors and tryptophan-rich foods
  • ·Response to SSRIs can be less predictable (clearing is already fast; blocking reuptake rebalances differently)

Your protocol priority:

  • Tryptophan and 5-HTP at moderate doses are generally well-tolerated
  • Support serotonin synthesis: B6, zinc, magnesium (cofactors for tryptophan hydroxylase)
  • Monitor for low-serotonin symptoms under sustained stress
  • Rhodiola and adaptogenic herbs well-matched for stress response

Supplement Evidence by Genotype

SupplementMAOA-LMAOA-HMechanism
Magnesium glycinate High priority High priorityNMDA receptor modulation; reduces excitatory overflow; cofactor for 5-HT synthesis
Vitamin B6 (P5P form) High priority High priorityCofactor for aromatic amino acid decarboxylase; required for serotonin and dopamine synthesis
Methylated B vitamins Critical ModerateSAMe production supports COMT pathway; reduces monoamine overflow in MAOA-L carriers
L-Theanine High priority ModerateIncreases GABA and alpha waves; buffers heightened emotional reactivity without sedation
Ashwagandha (KSM-66) High priority High priorityCortisol reduction; reduces HPA-axis reactivity; supports monoamine balance under stress
5-HTP Caution — low dose only Well-toleratedDirect serotonin precursor; MAOA-L may accumulate excess 5-HT; start ≤50mg with B6
Tryptophan Use dietary sources Supplement toleratedIndirect serotonin precursor; gentler than 5-HTP; turkey, eggs, pumpkin seeds preferred for MAOA-L
Rhodiola rosea Moderate — test first High priorityMild MAO-A inhibition + adaptogenic; too much MAO inhibition is counterproductive for MAOA-L
St. John's Wort Avoid Only with supervisionMAO-A inhibitor + serotonin reuptake inhibitor; excessive serotonin accumulation risk for MAOA-L
Zinc (bisglycinate) High priority High priorityModulates NMDA receptor; cofactor for tryptophan hydroxylase; anti-excitatory

Gene Interactions

MAOA doesn't operate alone. Its clinical relevance compounds significantly with variants in enzymes that work upstream and downstream in the same pathways.

COMT Val158MetCritical compound

COMT methylates catecholamines in the prefrontal cortex; MAOA oxidizes them more broadly. Slow COMT + MAOA-L creates a double bottleneck for dopamine and norepinephrine clearance. The combination produces significantly elevated catecholamine tone and heightened stress reactivity — requiring aggressive methylation support (methylfolate, methylB12) and lifestyle regulation.

SLC6A4 5-HTTLPRKey interaction

SLC6A4 controls serotonin reuptake; MAOA controls its degradation. Short/short 5-HTTLPR + MAOA-L creates compounding serotonin retention — neither reuptake nor clearance is working efficiently. The Caspi 2003 serotonin-depression study and the Caspi 2002 MAOA-maltreatment study are the two most replicated GxE findings in psychiatry, and they converge on the same population: high-sensitivity individuals.

BDNF Val66MetPlasticity modifier

BDNF regulates synaptic plasticity in the same limbic circuits MAOA modulates. Met carriers have reduced activity-dependent BDNF secretion. MAOA-L + BDNF Met compound the environmental sensitivity pattern: lower threshold for emotional encoding, stronger consolidation of both positive and negative experiences. Exercise (which increases BDNF) is doubly important for this combination.

MTHFR C677TMethylation upstream

MTHFR produces methylfolate → feeds SAMe → COMT uses SAMe to methylate dopamine/NE → these methylated catecholamines are then MAOA substrates. Slow MTHFR + MAOA-L means inadequate clearance at two different steps: methylation slows the COMT pathway and MAOA-L slows the oxidative pathway. B vitamin supplementation (methylfolate, methylB12, B6) addresses both bottlenecks simultaneously.

Dietary Considerations for MAOA-L Carriers

Because MAOA breaks down tyramine (a dietary monoamine), MAOA-L carriers have a meaningful functional similarity to people on MAO inhibitor medications. This doesn't mean strict dietary restriction — but awareness matters:

Generally favorable

  • · Turkey, chicken, eggs (tryptophan without tyramine load)
  • · Leafy greens, legumes (methylation support)
  • · Fatty fish, flaxseed (omega-3 anti-inflammatory)
  • · Fermented foods in moderation (probiotic benefit, low tyramine if fresh)
  • · Dark chocolate in small amounts (magnesium, modest theobromine)

Use caution (high tyramine load)

  • · Aged cheeses (cheddar, parmesan, blue cheese)
  • · Cured or fermented meats (salami, pepperoni)
  • · Overripe or fermented soy products (miso, soy sauce)
  • · Fava beans
  • · Large amounts of alcohol (especially red wine, beer)

Important context: These dietary interactions are subclinical for most MAOA-L carriers without other compounding variants. The risk is meaningful only when combined with slow COMT, impaired MTHFR methylation, or pharmacological MAO inhibitors. Most people with MAOA-L consume these foods without issue. The protocol goal is optimization, not restriction.

Biomarkers to Consider

Functional neurotransmitter metabolites

  • Urine 5-HIAA — serotonin metabolite; elevated in MAOA-L baseline
  • Urine VMA/HVA — norepinephrine/dopamine metabolites; Genova Diagnostics NutrEval covers these
  • Whole blood histamine — proxy for MAO activity broadly (MAOA also breaks down histamine)

Downstream markers

  • Homocysteine — elevated homocysteine impairs methylation, reducing COMT backup for MAOA pathway
  • RBC folate + B12 — cofactor status for methylation support
  • Plasma magnesium (RBC) — cofactor for serotonin synthesis and NMDA modulation
  • HRV (wearable) — indirect marker of ANS tone; low HRV correlates with stress reactivity pattern

Research Cited

1.Caspi A, et al. (2002). Role of genotype in the cycle of violence in maltreated children. Science, 297(5582), 851-854. doi:10.1126/science.1072290
2.Brunner HG, et al. (1993). Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science, 262(5133), 578-580.
3.Deckert J, et al. (1999). Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Human Molecular Genetics, 8(4), 621-624.
4.Belsky J, et al. (2009). Beyond diathesis stress: Differential susceptibility to environmental influences. Psychological Bulletin, 135(6), 885-908.
5.Fergusson DM, et al. (2011). MAOA, abuse exposure and antisocial behaviour: 30-year longitudinal study. British Journal of Psychiatry, 198(6), 457-463.
6.Guo G, et al. (2008). The VNTR 2 repeat in MAOA and delinquent behavior in adolescence and young adulthood. European Journal of Human Genetics, 16(5), 626-634.

Know Your MAOA Status

MAOA-L isn't a warning. It's a map. Combined with your COMT, SLC6A4, and BDNF status, it tells you exactly how your nervous system processes emotional input — and what to do about it. Upload your 23andMe or AncestryDNA file to get your complete neurotransmitter profile.

Analyze My Genome